Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Xeris Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2DICHLORPHENAMIDE

    02 5GLUCAGON

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : DARANIDE

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : DARANIDE

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DICHLORPHENAMIDE

    Xeris Pharmaceuticals

    Dosage Form : TABLET; ORAL

    Proprietary Name : DARANIDE

    Dosage Strength : 50MG **Federal Register ...

    Approval Date : 1982-01-01

    Application Number : 11366

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : KEVEYIS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : KEVEYIS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code : AB

    DICHLORPHENAMIDE

    Xeris Pharmaceuticals

    Dosage Form : TABLET; ORAL

    Proprietary Name : KEVEYIS

    Dosage Strength : 50MG

    Approval Date : 2015-08-07

    Application Number : 11366

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : GVOKE PFS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : GVOKE PFS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    GLUCAGON

    Xeris Pharmaceuticals

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Proprietary Name : GVOKE PFS

    Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML...

    Approval Date : 2019-09-10

    Application Number : 212097

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : GVOKE PFS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : GVOKE PFS

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    GLUCAGON

    Xeris Pharmaceuticals

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Proprietary Name : GVOKE PFS

    Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

    Approval Date : 2019-09-10

    Application Number : 212097

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : GVOKE HYPOPEN

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : GVOKE HYPOPEN

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    GLUCAGON

    Xeris Pharmaceuticals

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Proprietary Name : GVOKE HYPOPEN

    Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML...

    Approval Date : 2019-09-10

    Application Number : 212097

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : GVOKE HYPOPEN

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : GVOKE HYPOPEN

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    GLUCAGON

    Xeris Pharmaceuticals

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Proprietary Name : GVOKE HYPOPEN

    Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

    Approval Date : 2019-09-10

    Application Number : 212097

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : GVOKE KIT

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : GVOKE KIT

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    GLUCAGON

    Xeris Pharmaceuticals

    Dosage Form : SOLUTION; SUBCUTANEOUS

    Proprietary Name : GVOKE KIT

    Dosage Strength : 1MG/0.2ML (1MG/0.2ML)

    Approval Date : 2021-08-20

    Application Number : 212097

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place